Related Experiment Videos

[Clinicopathological study of Henoch-Schönlein purpura nephritis with special reference to C3c deposits]

K Kumada1, J Suzuki, K Kume

  • 1Department of Pediatrics, Fukushima Medical College, Japan.

Insights

Glomerular C3c deposits in Henoch-Schönlein purpura nephritis (HSPN) are linked to clinical outcomes in children. Complement activation appears early in HSPN, influencing disease progression and proteinuria duration.

Area of Science:

  • Nephrology
  • Pediatric Nephrology
  • Immunology

Background:

  • Henoch-Schönlein purpura nephritis (HSPN) is a common childhood vasculitis affecting the kidneys.
  • Glomerular C3c deposits are a characteristic finding in HSPN, but their clinical significance requires further elucidation.
  • Understanding the role of complement activation in HSPN is crucial for predicting disease course.

Purpose of the Study:

  • To evaluate the association between glomerular C3c deposits and clinical manifestations in pediatric HSPN patients.
  • To investigate the relationship between C3c deposits, proteinuria, hematuria, and histological findings.
  • To determine if C3c deposits indicate early complement activation in HSPN.

Main Methods:

  • Clinicopathological analysis of 51 children (aged 7-15) with HSPN.
  • Histological assessment using light and electron microscopy.
  • Comparative study of C3c-positive versus C3c-negative patient groups.

Main Results:

  • Crescent formation and subepithelial electron-dense deposits correlated with proteinuria and hematuria duration.
  • Glomerular C3c deposits were significantly more prevalent in patients with heavy proteinuria (65%) compared to mild proteinuria (30%).
  • C3c-positive patients showed a tendency for prolonged proteinuria/hematuria, with earlier biopsies performed in those with global C3c deposits.

Conclusions:

  • Glomerular C3c deposits appear to influence the clinical course of pediatric HSPN.
  • Complement activation is likely generated in the early stages of HSPN.
  • C3c deposition may serve as a biomarker for disease activity and duration in children with HSPN.

Related Concept Videos